| Authors: |
Whiteaker JR; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Zhao L; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Saul R; b Antibody Characterization Laboratory, Leidos Biochemical Research, Inc., Frederick National Laboratory for Cancer Research ATRF, Frederick, Maryland., Kaczmarczyk JA; b Antibody Characterization Laboratory, Leidos Biochemical Research, Inc., Frederick National Laboratory for Cancer Research ATRF, Frederick, Maryland., Schoenherr RM; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Moore HD; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Jones-Weinert C; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Ivey RG; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Lin C; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon., Hiltke T; c Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, Maryland., Reding KW; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon.; d School of Public Health, University of Washington, Seattle, Washington., Whiteley G; b Antibody Characterization Laboratory, Leidos Biochemical Research, Inc., Frederick National Laboratory for Cancer Research ATRF, Frederick, Maryland., Wang P; e Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York., Paulovich AG; a Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washingon. |